[Effectiveness of preseason serum prevention of hepatitis A using different doses of 10% commercial immunoglobulin].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to V B Iurkuvenas.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The prophylactic efficacy of 0.1 ml, 0.75 ml, and 1.5 ml 10% commercial immunoglobulin used in the preepidemic period was studied. The indices of morbidity among unvaccinees in the previous year were found to be significantly lower than in the control group whereas no such difference was observed in the group of children immunized in the previous year with 1.0 ml immunoglobulin. The incidence among the subjects repeatedly vaccinated with 0.75 ml and 1.5 ml was significantly higher than among previously nonimmunized children.